drugset / Trial / NCT00585208
Add-On Ramelteon in Bipolar I Disorder With Clinically Significant Sleep Disturbance
Phase 3
Terminated
21 enrolled
Lindner Center of HOPE
Takeda · collabUniversity of Cincinnati · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this research study is to evaluate the safety and efficacy of ramelteon (Rozerem™) as an add-on treatment for sleep problems in patients with bipolar disorder. This study will determine whether or not the addition of ramelteon to ongoing medication(s) for bipolar disorder is useful in improving sleep.
Timeline
- Start
- 2007-12
- Primary completion
- 2010-09
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ramelteon | Unknown | 8 mg | — |